Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 P1115 | DOI: 10.1530/endoabs.56.P1115

ECE2018 Poster Presentations: Thyroid Thyroid (non-cancer) (105 abstracts)

The significance of rare genetic variants in the thyroid autoimmunity – brief review and our own results on SLC26A4 variants in Hashimoto’s thyroiditis

Agata Jabrocka-Hybel 1 , Anna Skalniak 1 , Jakub Piętkowski 2 & Alicja Hubalewska-Dydejczyk 1

1Department of Endocrinology Jagiellonian University Medical College, Krakow, Poland; 2Unit of Endocrinology, University Hospital in Krakow, Krakow, Poland.

Identified genetic players for most common diseases are not sufficient to explain their heritability. This situation is known as the missing heritability problem. One among the possible explanations is the impact of rare variants. We present our own results of rare variants in the gene SLC26A4 in Hashimoto’s thyroiditis (HT), which were not found in controls, and therefore confirm the possibility of their impact on this disease. We genotyped 147 Hashimoto’s thyroiditis cases (10.2% men) and 147 controls (13.6% men) matched for age, gender, marital status, education, monthly income, and size of the city they live in. The gene SLC26A4 encoding for a iodine transporter was Sanger-sequenced in 20 HT cases, in order to identify new rare variants in this gene. We identified 2 new variants, which have not been previously reported. Two among the investigated SNPs were not differentially represented in both groups: c.-103T>C, previously associated with Pendred syndrome, and c.1708-18T>A, previously proven as benign. In contrast, variants located in the coding region, which have previously been assigned as benign or likely benign. Those included p.Ser190Arg (n=4 cases), p.Ile300Leu (n=3), p.Phe354Ser (n=3), p.Ala456Ala (n=2), p.Leu597Ser (n=4), p.Val609Gly (n=2) and p.Asp772Tyr (n=1). It seems very probable that rare variants are at least one of the reasons for missing heritability. It seems possible that the variants we identified in HT may play a joint role in HT, as most of them co-occurred in the same patients. Future studies should target genome-wide rare variants, as probably different genes will have a combined role in the risk of those diseases.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.